| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 1.14e-05 | 16 | 56 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 4.62e-05 | 4 | 56 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.18e-04 | 34 | 56 | 3 | GO:0046966 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 7.55e-06 | 15 | 54 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 7.55e-06 | 15 | 54 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.35e-05 | 18 | 54 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 4.02e-05 | 4 | 54 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 6.69e-05 | 5 | 54 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 8.75e-05 | 33 | 54 | 3 | GO:2000737 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.00e-04 | 6 | 54 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 1.05e-04 | 35 | 54 | 3 | GO:0048333 | |
| GeneOntologyBiologicalProcess | regulation of cell division | 1.79e-04 | 201 | 54 | 5 | GO:0051302 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 1.86e-04 | 8 | 54 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | stem cell division | 2.87e-04 | 49 | 54 | 3 | GO:0017145 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 2.99e-04 | 10 | 54 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 3.64e-04 | 11 | 54 | 2 | GO:0001714 | |
| Domain | JmjC | 2.25e-03 | 24 | 55 | 2 | PF02373 | |
| Domain | JMJC | 3.99e-03 | 32 | 55 | 2 | PS51184 | |
| Domain | JmjC_dom | 3.99e-03 | 32 | 55 | 2 | IPR003347 | |
| Domain | JmjC | 4.24e-03 | 33 | 55 | 2 | SM00558 | |
| Domain | Kinase-like_dom | 5.05e-03 | 542 | 55 | 6 | IPR011009 | |
| Domain | Pkinase_C | 5.31e-03 | 37 | 55 | 2 | IPR017892 | |
| Domain | Pkinase_C | 6.80e-03 | 42 | 55 | 2 | PF00433 | |
| Domain | C2 | 7.67e-03 | 137 | 55 | 3 | SM00239 | |
| Domain | C2 | 8.46e-03 | 142 | 55 | 3 | PS50004 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ANKRD36B SMG1 TGM3 IL31RA RNF2 UTP25 PKN2 ANKRD36 ANKRD36C MAP3K21 ACOX3 | 2.75e-07 | 910 | 58 | 11 | 36736316 |
| Pubmed | Bmi1 facilitates primitive endoderm formation by stabilizing Gata6 during early mouse development. | 3.67e-07 | 9 | 58 | 3 | 22713603 | |
| Pubmed | 5.24e-07 | 10 | 58 | 3 | 29101321 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 7.15e-07 | 302 | 58 | 7 | 30561431 | |
| Pubmed | 8.99e-07 | 44 | 58 | 4 | 24183668 | ||
| Pubmed | A mouse-specific retrotransposon drives a conserved Cdk2ap1 isoform essential for development. | 9.58e-07 | 12 | 58 | 3 | 34644528 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CYLD EPS8 TGM3 DIS3L TNRC6A PPP1R13B GIGYF2 MPHOSPH9 LRP1B CNN3 | 1.34e-06 | 853 | 58 | 10 | 28718761 |
| Pubmed | RBM19 is essential for preimplantation development in the mouse. | 1.97e-06 | 15 | 58 | 3 | 19087264 | |
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 2.73e-06 | 2 | 58 | 2 | 19415763 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24598770 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 2.73e-06 | 2 | 58 | 2 | 22079639 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 2.73e-06 | 2 | 58 | 2 | 21136380 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.99e-06 | 724 | 58 | 9 | 36232890 | |
| Pubmed | CYLD SMG1 NCOA3 RNF2 COPA DIS3L TNRC6A PPP1R13B GIGYF2 KDM6A ATP5PD JMJD1C | 3.42e-06 | 1429 | 58 | 12 | 35140242 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 5.73e-06 | 21 | 58 | 3 | 21337463 | |
| Pubmed | 6.63e-06 | 22 | 58 | 3 | 35640597 | ||
| Pubmed | 7.61e-06 | 23 | 58 | 3 | 9225980 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19447925 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 8.19e-06 | 3 | 58 | 2 | 30814124 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 8.19e-06 | 3 | 58 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 8.19e-06 | 3 | 58 | 2 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 8.19e-06 | 3 | 58 | 2 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 8.19e-06 | 3 | 58 | 2 | 18177668 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 8.19e-06 | 3 | 58 | 2 | 16259959 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12609610 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24227785 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 8.19e-06 | 3 | 58 | 2 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 8.19e-06 | 3 | 58 | 2 | 23770853 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15502159 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 8.19e-06 | 3 | 58 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 8.19e-06 | 3 | 58 | 2 | 23054952 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 8.19e-06 | 3 | 58 | 2 | 24527385 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18086680 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17204467 | ||
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 8.19e-06 | 3 | 58 | 2 | 19800316 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23200040 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 8.19e-06 | 3 | 58 | 2 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 8.19e-06 | 3 | 58 | 2 | 23329853 | |
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 8.19e-06 | 3 | 58 | 2 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 8.19e-06 | 3 | 58 | 2 | 17352742 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 8.19e-06 | 3 | 58 | 2 | 25005472 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16773043 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 8.19e-06 | 3 | 58 | 2 | 26733157 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23071603 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 8.19e-06 | 3 | 58 | 2 | 19582141 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21119109 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 32145514 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19703398 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 8.19e-06 | 3 | 58 | 2 | 18097409 | |
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 8.19e-06 | 3 | 58 | 2 | 28636920 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 8.19e-06 | 3 | 58 | 2 | 25753417 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20539761 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18584034 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21969378 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20661723 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 29245050 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22337995 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 8.19e-06 | 3 | 58 | 2 | 23333380 | |
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 8.19e-06 | 3 | 58 | 2 | 15494369 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 8.19e-06 | 3 | 58 | 2 | 31891567 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 8.19e-06 | 3 | 58 | 2 | 14728807 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 8.19e-06 | 3 | 58 | 2 | 15916719 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 8.19e-06 | 3 | 58 | 2 | 16845474 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 8.19e-06 | 3 | 58 | 2 | 21194951 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22388986 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16313224 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16791199 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 8.19e-06 | 3 | 58 | 2 | 33665763 | |
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 8.19e-06 | 3 | 58 | 2 | 18024963 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 27125671 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 8.19e-06 | 3 | 58 | 2 | 28457890 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 8.19e-06 | 3 | 58 | 2 | 18436640 | |
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 8.19e-06 | 3 | 58 | 2 | 25410303 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 33334884 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21499299 | ||
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 8.19e-06 | 3 | 58 | 2 | 33107035 | |
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 8.19e-06 | 3 | 58 | 2 | 17360937 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 35976266 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 8.19e-06 | 3 | 58 | 2 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 8.19e-06 | 3 | 58 | 2 | 30837263 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 8.19e-06 | 3 | 58 | 2 | 27939294 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24681518 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26586120 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26549484 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18442017 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21187909 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 8.19e-06 | 3 | 58 | 2 | 16541131 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 8.19e-06 | 3 | 58 | 2 | 22142851 | |
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 8.19e-06 | 3 | 58 | 2 | 24462001 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16790525 | ||
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.59e-05 | 25 | 42 | 3 | 775 | |
| GeneFamily | C2 domain containing protein kinases | 2.34e-04 | 10 | 42 | 2 | 835 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.41e-03 | 24 | 42 | 2 | 485 | |
| GeneFamily | Ankyrin repeat domain containing | 2.35e-03 | 242 | 42 | 4 | 403 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 1.14e-05 | 20 | 58 | 3 | M1189 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SMG1 NCOA3 FMO2 COPA TNRC6A GIGYF2 ROBO2 MAP3K21 KDM6A JMJD1C DCLK1 | 6.81e-06 | 790 | 57 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SMG1 NCOA3 FMO2 COPA TNRC6A GIGYF2 ROBO2 MAP3K21 KDM6A JMJD1C | 4.77e-05 | 801 | 57 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.33e-07 | 181 | 58 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.61e-07 | 187 | 58 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.88e-07 | 192 | 58 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.94e-07 | 193 | 58 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.00e-07 | 194 | 58 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-07 | 195 | 58 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.06e-07 | 195 | 58 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-07 | 195 | 58 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.12e-07 | 196 | 58 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-07 | 196 | 58 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-07 | 196 | 58 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-07 | 196 | 58 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-07 | 197 | 58 | 6 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-07 | 197 | 58 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.19e-07 | 197 | 58 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-07 | 197 | 58 | 6 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 2.19e-07 | 197 | 58 | 6 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-07 | 198 | 58 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.39e-07 | 200 | 58 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-07 | 200 | 58 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.86e-06 | 156 | 58 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-06 | 157 | 58 | 5 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.91e-06 | 171 | 58 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.84e-06 | 181 | 58 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.06e-06 | 183 | 58 | 5 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.51e-06 | 187 | 58 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.62e-06 | 188 | 58 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.75e-06 | 189 | 58 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.87e-06 | 190 | 58 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.87e-06 | 190 | 58 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.99e-06 | 191 | 58 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.99e-06 | 191 | 58 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.25e-06 | 193 | 58 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.25e-06 | 193 | 58 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.25e-06 | 193 | 58 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.25e-06 | 193 | 58 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.25e-06 | 193 | 58 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.39e-06 | 194 | 58 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.39e-06 | 194 | 58 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.39e-06 | 194 | 58 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.39e-06 | 194 | 58 | 5 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.39e-06 | 194 | 58 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 5.52e-06 | 195 | 58 | 5 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.52e-06 | 195 | 58 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.52e-06 | 195 | 58 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.52e-06 | 195 | 58 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 5.66e-06 | 196 | 58 | 5 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-06 | 196 | 58 | 5 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-06 | 196 | 58 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.66e-06 | 196 | 58 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 5.66e-06 | 196 | 58 | 5 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-06 | 196 | 58 | 5 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-06 | 196 | 58 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.81e-06 | 197 | 58 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.81e-06 | 197 | 58 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.81e-06 | 197 | 58 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.95e-06 | 198 | 58 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 5.95e-06 | 198 | 58 | 5 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-06 | 198 | 58 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.95e-06 | 198 | 58 | 5 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-06 | 198 | 58 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.95e-06 | 198 | 58 | 5 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.95e-06 | 198 | 58 | 5 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-06 | 198 | 58 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-06 | 198 | 58 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.10e-06 | 199 | 58 | 5 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.10e-06 | 199 | 58 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 18|World / Age, Tissue, Lineage and Cell class | 6.10e-06 | 199 | 58 | 5 | ef043232ee028778b8ddb92aeed7584e2bf586d5 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.10e-06 | 199 | 58 | 5 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.25e-06 | 200 | 58 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.25e-06 | 200 | 58 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-06 | 200 | 58 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-06 | 200 | 58 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.84e-05 | 145 | 58 | 4 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.05e-05 | 147 | 58 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.49e-05 | 151 | 58 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-05 | 160 | 58 | 4 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-05 | 160 | 58 | 4 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.91e-05 | 162 | 58 | 4 | fe546c2272a70bb5f08e6e097b9accdb891eda23 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.91e-05 | 162 | 58 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 165 | 58 | 4 | 369d77a80d6401e85ea3121ab5a252f67d5f157e | |
| ToppCell | Tuft-tuft-1|World / Class top | 6.80e-05 | 168 | 58 | 4 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | ca0c4a819f9047fc40d224f7656fec60f6fa05d8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-05 | 168 | 58 | 4 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-05 | 168 | 58 | 4 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.62e-05 | 173 | 58 | 4 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.14e-05 | 176 | 58 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.14e-05 | 176 | 58 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 177 | 58 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 177 | 58 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.07e-05 | 181 | 58 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 184 | 58 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 184 | 58 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.79e-05 | 195 | 57 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 3.92e-05 | 34 | 57 | 3 | EFO_0010368 | |
| Disease | schizophrenia, anorexia nervosa | 1.11e-04 | 48 | 57 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | colon cancer (implicated_via_orthology) | 1.99e-04 | 11 | 57 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Abnormality of the dentition | 2.39e-04 | 12 | 57 | 2 | HP_0000164 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 2.62e-04 | 64 | 57 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | stomach cancer (is_implicated_in) | 3.71e-04 | 72 | 57 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | mean arterial pressure | 3.97e-04 | 499 | 57 | 6 | EFO_0006340 | |
| Disease | response to angiotensin receptor blocker | 1.54e-03 | 30 | 57 | 2 | EFO_0010735 | |
| Disease | Antihypertensive use measurement | 1.73e-03 | 265 | 57 | 4 | EFO_0009927 | |
| Disease | uridine measurement | 1.75e-03 | 32 | 57 | 2 | EFO_0010546 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 1.75e-03 | 32 | 57 | 2 | EFO_0000341, EFO_0004325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASKPLASWTTQQGIQ | 406 | O15254 | |
| TQLFQKQKWTQVNPS | 1471 | P78363 | |
| PQNQKAIASSLKSWN | 21 | O75947 | |
| PVATWQNIQAAGTQK | 71 | Q16854 | |
| QQSGTVSSQKQPAWK | 1186 | A6QL64 | |
| QSGTVSSQKQPAWKA | 591 | Q8N2N9 | |
| SKSANDGNWPTLKQN | 381 | Q96KQ4 | |
| KWITKQQNAQGGFSS | 1236 | P01023 | |
| GQQSGTVSPQKQSAW | 641 | Q5JPF3 | |
| QQSGTVSSQKQLAWK | 1016 | Q5JPF3 | |
| NKQTPNKQIWLSSPS | 146 | Q16595 | |
| TLSKANKWTGQNVSV | 1491 | Q9NZR2 | |
| NKWTGQNVSVIQKTS | 1496 | Q9NZR2 | |
| QGLQVSTKQKVSPWD | 1661 | Q86YW9 | |
| SQATNWTIQQDKLKP | 376 | Q8NI17 | |
| IGQTATKQKTNSPAW | 51 | Q02156 | |
| SQTQGSKSKQIQWPA | 96 | Q15652 | |
| FNKSNKAASQQGTPW | 4386 | Q2LD37 | |
| PWKNQLSNSTQGLHK | 631 | O15550 | |
| VNPNWSVNVKTTSAS | 146 | O15075 | |
| TKASPVDSWKNQTFQ | 361 | Q99550 | |
| NNWPKNSNGVTQKAS | 156 | Q9H9S0 | |
| NVMVWNQNGKSPSIT | 311 | Q86TH1 | |
| TQSKTWTLNFNSVNK | 136 | A0A2R8Y4Y8 | |
| NDSTSTPQNANGLWK | 1036 | Q9Y2F5 | |
| TPQNANGLWKLKSTT | 1041 | Q9Y2F5 | |
| DKKQTWTVQNNGHSV | 76 | P22748 | |
| QQQQKLSGWGNVSKP | 981 | Q6Y7W6 | |
| SSNQKWVLAPKSQDT | 31 | Q99928 | |
| TKGTSPTQIWCNNSQ | 911 | P53621 | |
| QSQGKNAQKILVTPW | 356 | Q8TF46 | |
| TQWKTQIQNVSKSGG | 1066 | A8TX70 | |
| HSLDQQSKGWQSPKQ | 516 | Q96JA4 | |
| SSGQWKVVTQSNGKE | 121 | Q99518 | |
| KTWLQSKGFNPVTVN | 731 | Q12929 | |
| SSVDSQPQSKSKNTW | 361 | Q9NQC7 | |
| LASKSQSKWGPTSNN | 81 | A6NH13 | |
| SQPNSSKQTVLSWQA | 41 | Q01668 | |
| QTNGTQPLSKTWELS | 6 | Q99496 | |
| TWTKTNSQFLSGPQK | 256 | Q68CQ4 | |
| GNSPWSTILIKNQKT | 616 | Q5TCX8 | |
| SNNNSSSWLNVKGPL | 61 | A1L390 | |
| NNWPKNSNGVTQKAS | 156 | Q6NSW7 | |
| WIQSKINGPASLQTN | 806 | Q7RTY7 | |
| QKPSLTQQVSGWLQS | 331 | Q96Q15 | |
| KNLPKSTVNGVSWTN | 171 | Q9Y6Q9 | |
| WKSQDTKTTQGNGGQ | 156 | Q9NSC7 | |
| KSQQATAWTPTQQPG | 391 | A6NGB9 | |
| NTVVGQTSWKPISNQ | 401 | Q16513 | |
| TPQKQSNSNQWSEKG | 356 | Q8N1H7 | |
| TGKQWKNSVNSHTIG | 406 | Q08188 | |
| KWTDTLQGQVPSAQQ | 91 | Q5VW32 | |
| WEKISSQQNPNSNTL | 741 | P42695 | |
| QPGSVKKVNESSLNW | 66 | Q15417 | |
| SVTKSGRQCQPWNSQ | 326 | Q01973 | |
| QGTKTKSNTWSPKYN | 2101 | Q8NB66 | |
| TGNMWQKKANTPETQ | 2501 | Q99973 | |
| KNSSKPQKNNGSTWA | 1056 | Q9HCK4 | |
| VTGKWNSINSTKTND | 151 | Q9BXE9 | |
| NPKTWGRLSTQSNSN | 1046 | Q14669 | |
| TKWSAPQQNFLQGKT | 61 | Q9BR84 | |
| QNTGTNLPSVEWNKL | 606 | Q8NDV7 | |
| GKTSSFTWGNNINPN | 891 | Q8NDV7 | |
| SKQTGQWQSLAKLPT | 306 | Q2WGJ6 | |
| TWQKSTNGSKQNVAI | 66 | Q15223 |